News
Nearly three dozen global pharmaceutical companies, in a letter to the head of the European Commission, demanded help to ...
Experts say the tariffs are unlikely to bring back production of generic medicines, given their slim profit margins ...
Global drugmakers' stocks dropped across the board after U.S. President Donald Trump reiterated plans for a "major" tariff on ...
Trump said he would announce pharmaceutical tariffs, as he increased tariffs on China to 125% and paused tariffs for 75 ...
Europe's pharma sector now trails the US, it went on to say, "on every investor metric from availability of capital, ...
13d
24/7 Wall St. on MSN4 Blue Chip Pharmaceutical High-Yield Dividend Stocks Are Tariff WinnersLarge-cap pharmaceutical stocks like these may now be positioned to outperform as the impact of tariffs begins to take hold.
The US president vows "major" tariffs on imported medicines - raising fears of an increase in costs for Americans.
Emkay Global maintains a 'Buy' rating on Sun Pharma after the US Court of Appeals vacates the injunction against Leqselvi's ...
BofA lowered the firm’s price target on West Pharmaceutical (WST) to $280 from $285 and keeps a Buy rating on the shares. Sentiment for Life ...
The global pharmaceutical cold chain packaging market is set to witness remarkable growth, with market size projected to increase from USD 17.8 billion in 2025 to USD 32.2 billion by 2035, growing at ...
Global drugmakers’ stocks dropped across the board today after U.S. President Donald Trump reiterated plans for a “major” ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results